Ann: FDA End-of Phase 2 Status Update, page-46

I am not really one for speculative theories and this one probably isn't worth much, but what if PRANA's desire to increase the dosage was a relatively recent decision which has thrown a spanner into the previously progressing discussions between themselves and the FDA? Perhaps information suggesting the desirability of an increased dose has come to light post IMAGINE EXTENSION analysis? If the intention always was for an increased dosage, why didn't they take the necessary steps to seek approval for increased dosages over the past year?

[Remember the 'right drug, wrong dose' theories which surfaced BEFORE (early March 14) the announcement of the IMAGINE results (31 March 14 - oh no, not another reminder).